Central African Republic vs China: Treatment success rate for patients treated for MDR-TB
Central African Republic
69.0%
in 2021
China
68.0%
in 2022
Central African Republic rank
101st
China rank
104th
Treatment success rate for patients treated for MDR-TB over time
- Central African Republic
- China
How they compare
Central African Republic currently reports 69.0% against 68.0% in China, a difference of 1.0%.
Across all 10 years both countries report, Central African Republic has been ahead every year.
Central African Republic ranks 101st and China ranks 104th of 163 countries.
Central African Republic has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Central African Republic | China | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 75.0% | 49.0% | 26.0% | Central African Republic |
| 2020s | 74.5% | 58.5% | 16.0% | Central African Republic |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment success rate for patients treated for mdr-tb, Central African Republic or China?
- Central African Republic, at 69.0% against 68.0% in China as of 2021.
- What is the difference in treatment success rate for patients treated for mdr-tb between Central African Republic and China?
- 1.0%, with Central African Republic ahead.
- How many years of comparable data are there for Central African Republic and China?
- 10 years are reported by both, from 2012 to 2021.
- How do Central African Republic and China rank globally for treatment success rate for patients treated for mdr-tb?
- Central African Republic ranks 101st and China ranks 104th of 163 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Treatment success rate for patients treated for MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.